首页 | 本学科首页   官方微博 | 高级检索  
检索        

时辰化疗联合放疗治疗晚期食管癌
引用本文:韦淑贞,山顺林,张闯,张姣.时辰化疗联合放疗治疗晚期食管癌[J].肿瘤研究与临床,2009,21(8):471-472.
作者姓名:韦淑贞  山顺林  张闯  张姣
作者单位:解放军第八二医院放疗科,江苏淮安,223001
摘    要:目的探讨时辰化疗联合放疗治疗晚期食管癌的疗效。方法晚期食管癌患者80例,随机分为单纯放疗组(单放组)和时辰化疗联合放疗组(综合组),两组各40例。时辰化疗方法:顺铂(DDP)联合5-氟尿嘧啶(5-Fu)静脉滴注,DDP20mg/m^2,每日10时至22时给药,5-Fu 500mg/m^2,每日22时至次日10时给药,5d为1个疗程,第29天重复。放疗:综合组肿瘤剂量56~60Gy,照射5~6周;单放组肿瘤剂量64—70Gy,照射6~7周,观察患者治疗的效果及影像改善情况,随访6~20个月。结果综合组和单放组总有效率分别为92.5%(37/40)及75.0%(30/40),两组差异有统计学意义(P〈0.05);综合组和单放组患者1年生存率分别为75.0%(30/40)和52.5%(21/40),差异有统计学意义(P〈0.05);2年生存率分别为47.5%(19/40)和30.0%(12/40),差异有统计学意义(P〉0.05)。结论时辰化疗联合放疗是一种治疗晚期食管癌的有效方法。

关 键 词:食管肿瘤  抗肿瘤联合化疗方案  放射疗法  计算机辅助
收稿时间:2008-10-6

Chrono-chemotherapy with radiotherapy in treatment of advanced esophageal carcinoma
WEI Shu-zhen,SHAN Shun-lin,ZHANG Chuang,ZHANG Jiao.Chrono-chemotherapy with radiotherapy in treatment of advanced esophageal carcinoma[J].Cancer Research and Clinic,2009,21(8):471-472.
Authors:WEI Shu-zhen  SHAN Shun-lin  ZHANG Chuang  ZHANG Jiao
Institution:( Department of Radiotherapy, 82 Hospital of PLA, Huai'an 223001, China)
Abstract:Objective To investigate the treatment effects of chrono-chemotherapy (CC) with radiotherapy on advanced esophageal carcinoma. Methods Eighty patients with advanced esophageal carcinoma were randomly divided into two groups: a radiotherapy group (R) and a chrono-chemotherapy plus radiotherapy group (CC+R). 40 patients received radical radiotherapy alone and the radiation dose was 64-70 Gy for 6-7 weeks (R). 40 patients were treated by chrono--chemotherapy plus radiotherapy. Patients were chrono-introvein infusion with cisplatin and 5-fluorouraeil. Patients were given cisplatin 20 mg/m2 infusion on 10-hour-22-hour and 5-fluorouracil 500 mg/m2 by infusion from 22:00 to 10:00 next day. The period of treatment was 5 days. Treatment was repeated on the 29th day. The radiation dose was 50-60 Gy, for 5-6 weeks (CC+R). The treatment effects and X images of all patients were observed and followed up for 6 to 20 months. Results The improvements of clinical symptoms were 92.5% (37/40) in CC+R group and 75.0% (30/40) in R group, with an obvious difference between the two groups (P <0.05). The 1-, 2-year survival rates were 75.0% (30/40) and 52.5% (21/40), 47.5% (19/40) and 30.0% (12/40) in two groups, with significant difference in 1-year survival rate between the two groups (P <0.05). Conclusion Radiotherapy combined with chrono-chemotherapy was an effective method for advanced esophageal carcinoma.
Keywords:Esophageal neoplasms  Antineeplastic combined chemotherapy protocols  Radiotherapy  computer-assisted
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《肿瘤研究与临床》浏览原始摘要信息
点击此处可从《肿瘤研究与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号